Donate For Public and Patients Store Search

U024 - The Role of and Topical Therapies Involving Androgen Hormones in Acne and Androgenetic Alopecia (AGA)

Friday, March 1; 4:30 PM - 5:30 PM

Learning Objectives

Following this course, the attendee should be able to:

  • Discuss the role of androgens and hormones in the pathogenesis of acne and Androgenetic Alopecia (AGA)
  • Describe the mechanism of action, effectiveness and safety of topical anti-androgens and sebum reducers in the treatment of acne
  • Examine the role of anti-androgens and other therapies for Androgenetic Alopecia (AGA)

Description

This session will address the role of androgens and hormones in the pathogenesis of acne and Androgenetic Alopecia (AGA). The latest evidence regarding hormonal and anti-androgen treatments for acne and AGA will be discussed.

Disclosures

  • Green, Lawrence J., MD: AbbVie – SP(H); Aclaris Therapeutics Inc. – I(Grants/Research Funding); Almirall – SP(H); Amgen – SP(H); Brickell Biotech, Inc. – I(Grants/Research Funding); Cassiopea S.p.A. – C(NC); Celgene – A(H), I(Grants/Research Funding); Celgene Corporation – SP(H); Demira – A(H), SP(H); Eli Lilly and Company – I(Grants/Research Funding); Leo Pharma Inc. – SP(H); Novartis – C(H), SP(H); Ortho Dermatologics – SP(H); Revance Therapeutics, Inc. – I(Grants/Research Funding); Sienna Biopharmaceuticals – I(Grants/Research Funding); Sun Pharmaceutical Industries Ltd. – SP(H); Valeant Pharmaceuticals North America LLC – C(H), I(Grants/Research Funding); ZO Skin Health, Inc. – C(H);
  • Hebert, Adelaide A., MD: Allergan, Inc. – I(Grants/Research Funding); Almirall – A(H); Amgen – I(Grants/Research Funding), SP(H); Anacor Pharmaceuticals, Inc. – A(H); Astellas Pharma US, Inc – I(Grants/Research Funding); Bayer – SP(H); Bickel Biotechnology – I(Grants/Research Funding); Biofrontera – SP(H); Cassiopia – I(Grants/Research Funding); Celgene Corporation – I(Grants/Research Funding); Chugai Pharma – I(Grants/Research Funding); Cutanea Life Sciences – A(H), I(Grants/Research Funding); Department of DEFENSE – O(Grants/Research Funding); Dermavant Sciences – A(H), I(Grants/Research Funding); Dermira – A(H), I(Grants/Research Funding); Encore Dermatology, Inc. – A(H); Fall Clinical meeting – SP(H); Ferrer – C(H); Galderma Laboratories, L.P. – A(H), SP(H); GlaxoSmithKline – A(H), Data Safety Monitoring Board(H), I(Grants/Research Funding); Healthpoint – I(Grants/Research Funding); Intendis, Inc. – SP(H); La Roche-Posay Laboratoire Pharmaceutique – A(H); Mayne Pharma Group – I(Grants/Research Funding); Medimetriks Pharmaceuticals, Inc. – I(Grants/Research Funding); Menarini Group – SP(H); Menlo Therapeutics – A(H); Merz Pharmaceuticals, LLC – I(Grants/Research Funding); NIH – I(Grants/Research Funding); Novan – I(H); Novartis Pharmaceuticals Corp. – O(H); Onset Therapeutics – SP(H); Ortho Dermatologics – A(H); Pfizer Inc. – I(Grants/Research Funding), Speaker/Faculty Education(H); Pharmaderm – A(H); PPD Inc. – I(Grants/Research Funding); Prim-Med – SP(H); Promius Pharma, LLC – A(H); Promius Pharmaceuticals – A(H), I(Grants/Research Funding); Regeneron – Data Safety Monitoring Board(H); Roivant Sciences – A(H); Shionogi USA – A(IP); Sienna Biopharmaceuticals – I(Grants/Research Funding); Sinclair Pharma – SP(H); Spring Managed Care Forum – SP(H); Stiefel a GSK company – A(H); TopMD – I(Grants/Research Funding); Valeant Pharmaceuticals International – A(H), SP(H); Vanda Pharmaceuticals Inc. – I(Grants/Research Funding); Verrica Pharmaceuticals Inc – A(Fees);
  • Makredes Senna, Maryanne, MD: Cassiopia – A(Fees); Concert Pharmaceuticals – C(Fees); Follica – I(EQ);
  • Washenik, Ken, MD, PhD: Aclaris Therapeutics Inc. – C(H); Allergan, Inc – C(H); Almirall – A(H); Cassiopea S.p.A. – C(H); Cicatricial Alopecia Research Foundation – B(NC); Follica – A(H), A(SO); Hair Foundation – B(NC); International Society of Hair Restoration Surgery – B(NC); Kerastem – A(H); North American Hair Research Society – B(NC);
Schedule
Friday, March 1
4:30 PM
All faculty / The role of Topical Therapies involving Androgens in Acne and Androgenetic Alopecia
Event Details
  • Date
    Friday, March 1
  • Time
    4:30 PM - 5:30 PM
  • Location
    Room 207B
  • CME Credits
    1.00
  • Type
    New
Directors/Co-Directors
  • Lawrence J. Green, MD, FAAD
Speakers
  • Adelaide A. Hebert, MD, FAAD
  • Ken Washenik, MD, PhD, FAAD
  • Maryanne Makredes Senna, MD